SINGAPORE, Oct. 16 (Xinhua) -- A group of researchers in Singapore will tap their artificial intelligence (AI) platform to evaluate 12 locally available drugs to derive a combination of drugs that can be used to treat COVID-19, local media reported on Friday.
The interactive digital platform leverages AI to calculate the most effective combination of drugs - along with their respective doses - from more than 530,000 possibilities, the Straits Times reported. The research team will be evaluating a set of 12 locally accessible drugs, ranging from anti-virals to targeted therapies and other agents.
